MedPath

Stivarga

Brand Name: Stivarga

Generic Name: Regorafenib

Active
Registration Number

DR-XY43344

Dosage Form

Film-Coated Tablet

Issuance Date

March 1, 2024

Expiry Date

April 8, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg
PackagingWhite opaque HDPE Plastic Bottle x 28's with dessicant (Box of 1 bottle and Box of 3 bottles)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Automatic Renewal (E-AR)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

RegorafenibActive
Monograph: Regorafenib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform